SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-026838
Filing Date
2018-11-05
Accepted
2018-11-05 16:10:49
Documents
3
Period of Report
2018-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-8k_20181105.htm 8-K 25551
2 EX-99.1 drna-ex991_6.htm EX-99.1 212724
3 GRAPHIC gjc5u5f4kp1u000001.jpg GRAPHIC 4904
  Complete submission text file 0001564590-18-026838.txt   246287
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 181160014
SIC: 2834 Pharmaceutical Preparations